425: Strive CRO Reposts Semler Scientific Merger Update

Strive's Chief Risk Officer reposted a communication on X.com regarding the proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statements and associated risks.

Summary

• The communication, reposted by Strive's Chief Risk Officer Jeff Walton on November 10, 2025, relates to Strive's proposed business combination with Semler Scientific, Inc.
• It includes a cautionary statement regarding forward-looking statements concerning the merger's outlook, strategic and financial benefits, impact on future financial performance, closing timing, and integration success.
• Investors and stockholders are urged to read the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus for important information about both companies and the proposed transaction.
• The definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• The filing clarifies that it does not constitute an offer to sell or a solicitation of an offer to buy securities or a vote of approval.

Sentiment

Score: 6

Explanation: The filing is primarily a cautionary statement about a proposed merger, outlining potential benefits as forward-looking statements while detailing numerous risks. The tone is neutral to slightly cautious, typical for such disclosures.

Positives

• The proposed transaction is anticipated to yield strategic and financial benefits for the combined company.
• The merger is expected to positively impact the combined company's future financial performance.

Risks

• The merger agreement could be terminated by either Strive or Semler Scientific due to various circumstances.
• The proposed transaction may not close as expected or at all if closing conditions are not met timely.
• Legal proceedings could be instituted against Strive, Semler Scientific, or the combined company, impacting the transaction.
• Anticipated benefits, including cost savings and strategic gains, may not be realized, partly due to changes in Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, laws, and regulations could adversely affect the transaction.
• The integration of the two companies might be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction could be more expensive or take longer to complete than expected due to unforeseen factors.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction will cause dilution for existing shareholders.
• Potential adverse reactions from customers or changes to business or employee relationships could arise from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing could impact the transaction.

Future Outlook

The future outlook for the combined Strive and Semler Scientific entity includes expectations of strategic and financial benefits, improved future financial performance, and successful business integration, contingent upon the successful closing of the proposed transaction and effective management of identified risks.

Management Comments

• Jeff Walton, Chief Risk Officer of Strive, Inc., reposted the communication on X.com on November 10, 2025, in connection with the proposed business combination.

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests that the combined entity may be engaging with or exposed to the evolving digital asset landscape, a growing trend in corporate finance and investment strategies.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a potential risk factor.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is available in its definitive proxy statement for its 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Shareholders of Strive face potential dilution due to the issuance of additional Class A common stock in connection with the proposed transaction.
• Customers, business partners, and employees of both Strive and Semler Scientific could experience adverse reactions or changes to their relationships as a result of the merger announcement or completion.

Next Steps

• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Semler Scientific stockholders will vote to approve the proposed transaction.
• Strive and Semler Scientific will continue to file relevant documents with the SEC regarding the proposed transaction.

Key Dates

Keywords

Strive Inc, Semler Scientific Inc, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Bitcoin Treasury, Digital Assets, Corporate Governance